Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

08.06.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
08.06.22	This Day Last Year: Pfizer's Pneumococcal Vaccine Was Approved (RTTNews)
07.06.22	Hardman & Co Life Sciences Research: Long-term cost and EBIT analysis of the pharmaceutical industry (EQS Group)
06.06.22	Pfizer To Invest $120 Mln Kalamazoo Facility To Produce COVID-19 Oral Treatment (RTTNews)
06.06.22	Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S. (Businesswire)
04.06.22	Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® (palbociclib) for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer (Businesswire)
02.06.22	Pfizer Seeks FDA Authorization For Covid Vaccine For Children Under 5 (RTTNews)
01.06.22	Pfizer Provides Update on Ownership Interest in Haleon (Businesswire)
31.05.22	Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Expanding Access & Affordability (Businesswire)
26.05.22	FDA Grants Fast Track Designation To Pfizer's Ervogastat Combination For Liver Disease Treatment (RTTNews)
26.05.22	Pfizer Granted FDA Fast Track Designation for Ervogastat/Clesacostat Combination for the Treatment of Non-Alcoholic Steatohepatitis (NASH) (Businesswire)
25.05.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
25.05.22	Pfizer To Offer Medicines, Vaccines To 45 Lower-income Countries On Not-for-profit Basis (RTTNews)
25.05.22	Pfizer Launches ‘An Accord for a Healthier World’ to Improve Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries (Businesswire)
24.05.22	Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis (Businesswire)
23.05.22	Pfizer-BioNTech's Covid Vaccine For Kids Under 5 Demonstrates Efficacy Of 80.3% In Phase 2/3 Trial (RTTNews)
23.05.22	Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose (Businesswire)
20.05.22	CDC Recommends Pfizer COVID-19 Booster Shot For Children 5 To 11 (RTTNews)
17.05.22	FDA Authorizes Pfizer Covid-19 Booster Dose For Children Between 5-11yrs (RTTNews)
17.05.22	Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age (Businesswire)
17.05.22	Statement of changes in beneficial ownership of securities (RSS)
12.05.22	Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress (PR Newswire)
10.05.22	Pfizer To Buy Remaining Stake In Biohaven Pharma For $148.50/share In Cash - Quick Facts (RTTNews)
10.05.22	Pfizer to Acquire Biohaven Pharmaceuticals (Businesswire)
06.05.22	Myovant : FDA Extends Review Of Myfembree In Pain Associated With Endometriosis To August 6 (RTTNews)
03.05.22	Pfizer Q1 Profit Rises; Cuts Adj. EPS Outlook To Reflect Impact For Accounting Policy Change (RTTNews)
03.05.22	Pfizer Inc. Q1 Profit Increases, beats estimates (RTTNews)
03.05.22	Pfizer Reports First-Quarter 2022 Results (Businesswire)
30.04.22	Pfizer's COVID-19 Pill Fails To Prevent Symptomatic Infections (RTTNews)
29.04.22	Form 4 78003 (RSS)
28.04.22	Pfizer Declares Second-Quarter 2022 Dividend (Businesswire)
27.04.22	Pfizer-Biohaven Get EU's Marketing Authorization For VYDURA For Migraine Treatment (RTTNews)
27.04.22	Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine (Businesswire)
27.04.22	Pfizer Asks FDA To Authorize COVID-19 Booster Dose For Children 5 To 11 Years (RTTNews)
26.04.22	Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate (Businesswire)
26.04.22	Valneva, Pfizer Report Positive Phase 2 Pediatric Data For Lyme Disease Vaccine Candidate, VLA15 (RTTNews)
25.04.22	Pfizer Recalls Accupril (Quinapril HCl) Tablets (RTTNews)
19.04.22	Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28 (Businesswire)
14.04.22	Pfizer/BioNTech's Booster Dose Of Covid-19 Vaccine Demonstrates High Immune Response In Children (RTTNews)
14.04.22	Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age (Businesswire)
14.04.22	Form 4 78003 (RSS)
12.04.22	Myovant : FDA Identifies 'deficiencies' In SNDA Review Of Myfembree On Endometriosis-related Pain (RTTNews)
12.04.22	Form 8-K 78003 (RSS)
11.04.22	Pfizer Names David Denton To Succeed Frank D'Amelio As CFO And EVP (RTTNews)
11.04.22	Pfizer Names David M. Denton Chief Financial Officer (Businesswire)
11.04.22	Additional definitive proxy soliciting materials and Rule 14(a)(12) material (RSS)
07.04.22	Pfizer To Acquire ReViral For Up To $525 Mln (RTTNews)
07.04.22	Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates (Businesswire)
07.04.22	Form SC 13D/A 78003 (RSS)
06.04.22	Form DEFA14A 78003 (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

21.11.24		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
21.11.24		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
21.11.24		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
21.11.24		SDAX aktuell: SDAX zum Handelsende auf grünem Terrain
21.11.24		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
21.11.24		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
21.11.24		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
21.11.24		Roche-Aktie stabil: Swissmedic genehmigt subkutane Version von Ocrevus

21.11.24

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

21.11.24

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

21.11.24

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

21.11.24

SDAX aktuell: SDAX zum Handelsende auf grünem Terrain

21.11.24

Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen

21.11.24

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone